What we do

Omixon is a global biotechnology company that commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA™ product combines a targeted HLA Assay and the Omixon HLA Twin™ software to deliver the most accurate high-resolution HLA genotyping available. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR and ABO.


Testimonials


Omixon Blog

Omixon Upgrade Holotype HLA to 7 Loci

Omixon announce that Holotype HLA™, a HLA genotyping product that is NGS-based and provides the most complete and accurate characterization of the HLA genes, will be extended from five to seven HLA loci. Launched with five loci (HLA-A, B, C, …more

By kriszta.katona 0 comments

High Accuracy and High Precision HLA Typing Using Illumina Reads: Typing Algorithm and Perspectives on Novel Allele Discovery

Authors: György Horváth, Krisztina Rigó, Tim Hague, Attila Bérces, Szilveszter Juhos Abstract: Wide acceptance of high-throughput next-generation sequencers in medicinal genomics and clinics brought the promise of fast HLA typing. We are presenting the algorithmic challenges and workflow of HLA …more

By kriszta.katona 0 comments